Grant: Alliance Grants
University of Victoria
$25,000.00
Development of novel bioinks for 3D printing the neuromuscular junction
EF 2024-25
Résumé
3D bioprinting produces defined constructs from cells and bioactive molecules in a layer-by-layer fashion with high resolution and accuracy. The goal of this project is to establish an international collaboration with Dr. Marian Hettiaratchi and Dr. Gabriella Lindberg (both early career researchers at the University of Oregon) to develop and validate a novel bioink for bioprinting in vitro models of the neuromuscular junction. This project will use the expertise of the team members to develop a bioink capable of supporting both muscle and nerve cells along with determining the appropriate conditions to culture these structures. These bioprinted constructs will be evaluated for their viability and structure to see how closely they replicate the structures found in the neural muscular junction while encouraging trainees to learn new skills. We hypothesize that 3D bioprinting will be effective in creating a precise model of neuromuscular junction that can be used to serve as a tool for drug screening - providing an alternative method for drug testing to commonly used animal models. This project develops an important application of 3D bioprinting and will train highly qualified personnel in this rapidly growing research area from both Canada and United States while promoting international collaboration in Cascadia.
Programme
Alliance Grants
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
592408-2023
Name nom
Willerth, Stephanie SM
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Development of novel bioinks for 3D printing the neuromuscular junction
Keywords
3d bioprinting; biomaterials; cell biology; muscle; neuroscience; stem cells; tissue engineering
Application summary
3D bioprinting produces defined constructs from cells and bioactive molecules in a layer-by-layer fashion with high resolution and accuracy. The goal of this project is to establish an international collaboration with Dr. Marian Hettiaratchi and Dr. Gabriella Lindberg (both early career researchers at the University of Oregon) to develop and validate a novel bioink for bioprinting in vitro models of the neuromuscular junction. This project will use the expertise of the team members to develop a bioink capable of supporting both muscle and nerve cells along with determining the appropriate conditions to culture these structures. These bioprinted constructs will be evaluated for their viability and structure to see how closely they replicate the structures found in the neural muscular junction while encouraging trainees to learn new skills. We hypothesize that 3D bioprinting will be effective in creating a precise model of neuromuscular junction that can be used to serve as a tool for drug screening - providing an alternative method for drug testing to commonly used animal models. This project develops an important application of 3D bioprinting and will train highly qualified personnel in this rapidly growing research area from both Canada and United States while promoting international collaboration in Cascadia.